NVAX: Massive Bull Pennant Breakout | 9/10 Confluence SignalNovavax, Inc.BATS:NVAXTaxpayerTrades### 1. The Macro Picture: Bull Pennant Breakout Looking at the weekly timeframe, **Novavax (NVAX)** has successfully broken out of a massive, multi-month **Bull Pennant ** consolidation pattern. We are currently **47 bars past the initial breakout point**, confirming that this isn't just a sudden fakeout, but a sustained structural shift. The system is printing a firm **Weekly Bullish** trend with an active **Long Bias**. ### 2. Confluence & Trend Health What makes this setup highly reliable is the **9 / 10 Confluence Score** from the AlphaX FORGE framework, showing strong structural and volume alignment. Meanwhile, the **Chop Index is sitting at 60**. This high reading indicates that while the macro trend is bullish, the price is currently locked in a healthy compression/consolidation phase on the shorter timeframes. Think of it as storing energy for the next explosive leg upward. ### 3. The Execution Strategy & Key Levels The risk-to-reward metrics on this setup are exceptionally clean: * **Current Consolidation:** We are holding strong at **$9.33**, floating right above our initial entry trigger. * **The Base/Entry Trigger:** **$6.66** remains the historical invalidation flip zone. * **Take Profit 1 (TP1):** **$10.19** is our immediate overhead target (offering a **1.99 R:R**). * **Take Profit 2 (TP2):** **$13.72** is the ultimate macro target near the top of the historical structure (locking in a **3.99 R:R**). * **Invalidation / Stop Loss:** A weekly close below **$4.89** completely ruins the integrity of this pennant structure. ### 4. The Upcoming Catalyst Keep a close eye on the calendar—the next earnings report drops in **32 days**. Given the high-beta nature of biotechnology stocks, this upcoming binary event will likely provide the exact volume expansion needed to break out of the current "chop zone" and rapidly drive the price toward our targets. --- **⚠️ Disclaimer:** *This analysis is for educational and informational purposes only and does not constitute financial, investment, or trading advice. Trading stocks and options involves significant risk of loss. Always conduct your own thorough research and consult with a licensed professional before making any financial decisions.*